<DOC>
	<DOCNO>NCT00547014</DOCNO>
	<brief_summary>Determine safety tolerability study drug , CPG 52364 , give liquid capsule . Another purpose determine drug enters leave blood stream body tissues time .</brief_summary>
	<brief_title>First Safety Study Humans Single Dose CPG 52364</brief_title>
	<detailed_description />
	<criteria>Normal body mass index weight No significant diseases medical history clinically significant finding physical exam , opthalmologic exam , clinical laboratory evaluation 12lead electrocardiogram Current illness history medical condition affect body 's function Use medication within 7 day , immunosuppressive medication within 6 month , investigational drug within 30 day vaccine immunoglobulin within 90 day Use medication study Positive TB test Smoking within 6 month Pregnancy risk Pregnancy Alcohol drug misuse within 60 day Sensitivity quinazolines</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>treatment , parallel assignment , double blind , randomize , placebo control , safety study , SLE ( Systemic Lupus Erythematosus )</keyword>
</DOC>